as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.45%
Downside
1.48%
Upside
52 Week's Low
52 Week's High
62.55%
Downside
1.95%
Upside
Check Ideaya Biosciences Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.2B
EPS (TTM)
-1.2123
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-21.52
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-206.3M
Revenue (TTM)
214.8M
Profit Margin
-74.82%
Return On Equity TTM
-14.15%
Track how Ideaya Biosciences Inc P/E has moved over time to understand its valuation trends.
Ideaya Biosciences Inc in the last 5 years
Lowest (-21.40x)
June 30, 2021
Today (-21.52x)
December 6, 2025
Industry (8.21x)
December 6, 2025
Highest (-5.06x)
June 30, 2025
Today’s Price to Earnings Ratio: -21.52x
Compare market cap, revenue, PE, and other key metrics of Ideaya Biosciences Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.2B | 129.94% | -21.52 | -74.82% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Ideaya Biosciences Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ideaya Biosciences Inc investment value today
Current value as on today
₹1,35,388
Returns
₹35,388
(+35.39%)
Returns from Ideaya Biosciences Inc Stock
₹29,219 (+29.22%)
Dollar Returns*
₹6,168 (+6.17%)
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for Ideaya Biosciences Inc. Average target price of $49.47
Get share price movements and forecasts by analysts on Ideaya Biosciences Inc.
What analysts predicted
27.41%UPSIDE
Target Price
$49.47
Current Price
$35.91
Analyzed by
17 Analysts
Target
$49.47
Ideaya Biosciences Inc target price $49.47, a slight upside of 27.41% compared to current price of $35.91. According to 17 analysts rating.
Search interest for Ideaya Biosciences Inc Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -77.49M → 119.24M (in $), with an average increase of 165.0% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 3.92M → 207.83M (in $), with an average increase of 70.3% per quarter
Price Rise
![]()
In the last 1 month, IDYA stock has moved up by 18.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 977.7% return, outperforming this stock by 874.0%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 141.5%
| Organisation | Ideaya Biosciences Inc |
| Headquarters | 5000 Shoreline Court, South San Francisco, CA, United States, 94080 |
| Industry | Biotechnology |
| CEO | Mr. Yujiro S. Hata |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Andres Ruiz Briseno CPA | Chief Accounting Officer |
Dr. Paul A. Barsanti Ph.D. | Chief Technology Officer |
Mr. Douglas B. Snyder | Senior VP & General Counsel |
Dr. Joshua Bleharski Ph.D. | Chief Financial Officer |
Ms. Francine Zelaya | Vice President & Head of Human Resources |
Mr. Mick O'Quigley | Chief of Staff & Clinical Development |
Mr. Yujiro S. Hata | Founder, President, CEO & Director |
Dr. Michael A. White Ph.D. | Chief Scientific Officer |
Dr. Darrin M. Beaupre M.D., Ph.D. | Chief Medical Officer |
Mr. Stuart C. Dorman | Chief Commercial Officer |
Ideaya Biosciences Inc share price today is $35.91 as on at the close of the market. Ideaya Biosciences Inc share today touched a day high of $36.44 and a low of $35.39.
Ideaya Biosciences Inc share touched a 52 week high of $36.61 on and a 52 week low of $13.45 on . Ideaya Biosciences Inc stock price today i.e. is closed at $35.91,which is 1.91% down from its 52 week high and 166.99% up from its 52 week low.
Ideaya Biosciences Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ideaya Biosciences Inc (IDYA) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Ideaya Biosciences Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ideaya Biosciences Inc share’s latest price of $35.91 as on December 6, 2025 at 2:29 am IST, you will get 0.2785 shares of Ideaya Biosciences Inc. Learn more about
fractional shares .
Ideaya Biosciences Inc stock has given 129.94% share price returns and 22.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?